Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.
|
J Natl Compr Canc Netw
|
2010
|
2.45
|
2
|
Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy.
|
J Clin Oncol
|
2010
|
2.20
|
3
|
Case of the Massachusetts General Hospital: Case 35-2013: a 77-year-old man with confusion and malaise.
|
N Engl J Med
|
2013
|
1.98
|
4
|
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
|
Am J Surg Pathol
|
2010
|
1.88
|
5
|
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.
|
Biol Blood Marrow Transplant
|
2011
|
1.62
|
6
|
Primary subcutaneous Alternaria alternata infection of the hand in an immunocompromised host.
|
Med Mycol
|
2011
|
1.47
|
7
|
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.
|
Leuk Lymphoma
|
2012
|
1.45
|
8
|
Evaluating the impact of the humanities in medical education.
|
Mt Sinai J Med
|
2009
|
1.39
|
9
|
Diagnosis and management of Castleman disease.
|
Cancer Control
|
2014
|
1.32
|
10
|
Non-Hodgkin's lymphomas, version 1.2013.
|
J Natl Compr Canc Netw
|
2013
|
1.20
|
11
|
Non-Hodgkin's lymphomas, version 4.2014.
|
J Natl Compr Canc Netw
|
2014
|
1.17
|
12
|
Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).
|
Clin Cancer Res
|
2006
|
1.11
|
13
|
Non-Hodgkin's lymphomas.
|
J Natl Compr Canc Netw
|
2011
|
1.06
|
14
|
Non-Hodgkin's Lymphomas, version 3.2012.
|
J Natl Compr Canc Netw
|
2012
|
1.03
|
15
|
Non-Hodgkin's lymphomas, version 2.2014.
|
J Natl Compr Canc Netw
|
2014
|
0.94
|
16
|
Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease.
|
Leuk Lymphoma
|
2013
|
0.89
|
17
|
Diffuse Large B-Cell Lymphoma Version 1.2016.
|
J Natl Compr Canc Netw
|
2016
|
0.89
|
18
|
HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.
|
Adv Hematol
|
2012
|
0.88
|
19
|
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
|
Cancer
|
2014
|
0.86
|
20
|
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma.
|
Haematologica
|
2012
|
0.83
|
21
|
Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia.
|
J Clin Oncol
|
2009
|
0.82
|
22
|
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.
|
J Natl Compr Canc Netw
|
2015
|
0.81
|
23
|
Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.
|
Br J Haematol
|
2013
|
0.81
|
24
|
Kaposi's Sarcoma-Associated Herpesvirus-Related Solid Lymphoma Involving the Heart and Brain.
|
AIDS Res Treat
|
2011
|
0.79
|
25
|
Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.
|
Neurology
|
2013
|
0.78
|
26
|
Case 35-2013: A man with confusion and malaise.
|
N Engl J Med
|
2014
|
0.75
|
27
|
Adult T-cell leukemia/lymphoma: complexities in diagnosis and novel treatment strategies.
|
Oncology (Williston Park)
|
2009
|
0.75
|
28
|
High-dose chemotherapy and autologous stem cell transplantation for secondary central nervous system lymphoma: many are called, but few are chosen.
|
Haematologica
|
2013
|
0.75
|
29
|
R-CHOP: does one size fit all in diffuse large B cell lymphoma?
|
Acta Haematol
|
2013
|
0.75
|
30
|
Chemotherapy-sparing treatment strategies for follicular lymphoma: current options and future directions.
|
Curr Opin Hematol
|
2016
|
0.75
|
31
|
Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
|
J Natl Compr Canc Netw
|
2017
|
0.75
|
32
|
Case records of the Massachusetts General Hospital. Case 24-2010. A 56-year-old woman with a history of Hodgkin's lymphoma and sudden onset of dyspnea and shock.
|
N Engl J Med
|
2010
|
0.75
|
33
|
Unanswered Questions in HIV Hematology.
|
Adv Hematol
|
2012
|
0.75
|